Bronchial Trans-epithelial Transport in Patients With Idiopathic Multiple Dilations of the Bronchi
NCT ID: NCT02586883
Last Updated: 2021-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2016-03-29
2020-11-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Peripheral Endothelial Function in Asthmatic Patients
NCT02593344
Lung Hyperinflation and Response to Pulmonary Vasodilator Therapy
NCT06613321
Target Validation and Discovery in Idiopathic Bronchiectasis
NCT03750734
Bronchial Inflammation in Patients With Bronchiolithis Obliterans
NCT01633385
Study of the Use of Non-invasive Ventilation in Bronchial Dilatation Disease
NCT06987461
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The purpose of this study is to identify the abnormalities of bronchial trans-epithelial transport of chloride, sodium and bicarbonate in patients with idiopathic dilations of the bronchi, in comparison to two others groups of patients (without abnormality of ionic transport/with typical cystic fibrosis).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with multiple bronchi dilations
bronchial ddp test
bronchial ddp test during endoscopy, nasal smear, bronchial smear
Control patients without transport abnormality
bronchial ddp test
bronchial ddp test during endoscopy, nasal smear, bronchial smear
Patients with typical cystic fibrosis
bronchial ddp test
bronchial ddp test during endoscopy, nasal smear, bronchial smear
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
bronchial ddp test
bronchial ddp test during endoscopy, nasal smear, bronchial smear
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 2 and 20 years.
* Patient weighing more than 12kg
* Patients with a scheduled bronchoscopy under clinical monitoring (assessment of bronchial involvement, local samples for bacteriological and histological examination)
* Signature of consent by the patient or by the / the holder (s) of parental authority and the investigator
* Patient affiliated to a social security scheme or entitled
* Patient with contraception (for woman of childbearing age) Specific criteria for idiopathic bronchiectasis patients Patient with idiopathic bronchiectasis in at least two lobes, diagnosis made after extensive screening of known acquired or congenital causes
Specific criteria for "control" patients without abnormal ion transport
* Patient Not having bronchiectasis s or any supposed alteration in transepithelial ion transport
* Patients with fiberoptic bronchoscopy performed for one of the following indications:
* Pulmonary malformations
* Laryngeal, tracheal, bronchomalacia
* Airway compression
* Interstitial pathology
* Suspicion of foreign body
* Suspected tuberculosis Specific criteria for patients with a typical form of cystic f ibrosis (CF) Patient carrying 2 causing mutations in the CFTR gene (according to CFTR2 database; http://www.cftr2.org/mutations\_history.php) and sweat test\> 60 milliequivalent per liter (mEq/L).
Exclusion Criteria
* Smoking passive or active
* Not essential bronchial endoscopy in the clinical follow
* Extension of bronchoscopy time attributed to the difference in potential bronchial incompatible with the patient's general status
* Patient pregnant or breast feeding
* Hypersensitivity or cons known contraindications to health products for measurement of DDP (isoproterenol, Amiloride, ATP)
Specific criteria for idiopathic DDB patients
Presence of other congenital or acquired etiologies of DDB:
* Typical or atypical cystic fibrosis,
* Immunodeficiency,
* Primary ciliary dyskinesia,
* Abnormal bronchial wall structure (Williams-Campbell syndrome, Mounier-Kuhn, Ehlers-Danlos syndrome, Marfan's disease)
* Infectious DDBs post
* Extrinsic or endobronchial obstruction (foreign body, malformation, middle lobe syndrome)
* Chronic inhalation (GERD, swallowing disorders, gastroesophageal tracheal fistula)
* Allergic bronchopulmonary aspergillosis,
* System disease.
2 Years
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Necker-Enfants Malades Hospital
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2015-A00731-48
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.